IDEAYA Biosciences Inc.
IDYA | NASDAQ
$39.67
+$0.81 (+2.08%)
Sep 22, 2026, 1:21 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -210.99M | -98.54M | -83.27M | 119.24M | -77.49M | -72.18M | -130.31M | -51.82M | -52.77M | -39.57M | -33.96M | -27.44M | -27.93M | -23.64M | -24.2M | 1.62M | -22.06M | -14.01M | -18.21M | -11.58M | -10.95M | -9.02M |
Depreciation & Amortization | 2.26M | 1.14M | 1.2M | 1.03M | 1.23M | 1.13M | 643K | 1.01M | 1.1M | 1.08M | 1.02M | 1.03M | 998K | 960K | -492K | 925K | 860K | 808K | 448K | 780K | 1.09M | 382K |
Stock-Based Compensation | 31.19M | 14.54M | 11.79M | 12.22M | 11.87M | 10.24M | 9.49M | 9.22M | 9.73M | 6.31M | 4.8M | 5.3M | 4.73M | 3.66M | 2.98M | 3M | 3.04M | 2.61M | 2.06M | 2.2M | 2.06M | 1.92M |
Other Working Capital | 4.44M | 5.85M | -17.83M | 10.51M | 4.97M | 1.52M | 452K | 1.68M | 5.99M | -4.87M | -4.22M | -1.38M | -3.44M | -7M | -4.16M | 278K | -3.47M | -10.67M | -1.33M | -5.01M | -7.71M | -6.67M |
Other Non-Cash Items | -2.23M | -1.21M | -1.52M | -1.98M | -2.69M | -3.78M | -4.92M | -5.36M | -6.64M | -6.31M | 33.96M | -3.57M | -2.55M | -1.56M | -1.13M | -26.83M | 169K | 349K | 469K | 466K | 445K | 454K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -37.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 16.38M | 8.9M | -18.69M | 11.71M | 4.61M | 4.24M | 3.45M | -2.28M | 15.7M | -5.32M | 8.26M | -5.5M | -8.71M | -7.26M | -525K | -2.88M | -2.01M | -9.4M | -1.43M | -4.33M | -5.57M | -7.46M |
Operating Cash Flow | -163.38M | -75.17M | -90.5M | 142.21M | -62.47M | -60.34M | -121.66M | -49.23M | -32.88M | -43.81M | -23.75M | -30.17M | -33.46M | -27.84M | -23.37M | -24.17M | -19.99M | -19.65M | -16.66M | -12.47M | -12.93M | -13.72M |
Capital Expenditures | -1.83M | -967K | -333K | -42K | -663K | -1.33M | -1.1M | -457K | -973K | -1.33M | -838K | -603K | -884K | -43K | n/a | -1.1M | -1.94M | -401K | -605K | -458K | -578K | -1M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 111.11M | -51.95M | 120.5M | -23.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -356.04M | -42.61M | -236.14M | -138.99M | -127.55M | -105.21M | -337.04M | -213.72M | -164.76M | -475.78M | -221.61M | -81.83M | -220.25M | -72.3M | -65.5M | -88.09M | -37.92M | -64.3M | -32.57M | -149.38M | -94.31M | -38.74M |
Sales Maturities Of Investments | 320.9M | 162.53M | 138.95M | 180.8M | 174.13M | 186.35M | 141.03M | 194.15M | 234.29M | 123.14M | 110.5M | 133.78M | 99.75M | 95.86M | 55.23M | 70.5M | 53.18M | 46.94M | 32.76M | 93.53M | 45.51M | 76.18M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -111.11M | 51.95M | -120.5M | 23.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -36.98M | 118.95M | -97.53M | 41.77M | 45.92M | 79.82M | -197.11M | -20.04M | 68.56M | -353.97M | -111.94M | 51.35M | -121.38M | 23.52M | -10.28M | -18.68M | 13.32M | -17.76M | -413K | -56.31M | -49.38M | 36.44M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 1.13M | 3.16M | n/a | 2.86M | n/a | 13.48M | 1.86M | 37.26M | 366K | n/a | 147K | n/a | n/a | n/a | n/a | n/a | 112K |
Financial Cash Flow | 360.39M | 1.18M | 2.13M | 301K | 1.21M | 26.14M | 2.75M | 286.5M | 39.18M | 349.11M | 140.89M | 27.83M | 191.06M | 2.93M | 324K | 95.7M | 491K | 653K | 688K | 86.78M | 15.99M | 42M |
Net Cash Flow | 160.03M | 44.7M | -186.1M | 184.28M | -15.35M | 45.62M | -316.01M | 217.23M | 74.86M | -48.67M | 5.93M | 49.01M | 36.22M | -1.4M | -33.32M | 52.85M | -6.19M | -36.76M | -16.38M | 18M | -46.33M | 64.72M |
Free Cash Flow | -165.21M | -76.14M | -90.83M | 142.17M | -63.14M | -61.67M | -122.76M | -49.69M | -33.86M | -45.14M | -24.59M | -30.78M | -34.34M | -27.89M | -23.37M | -25.27M | -21.93M | -20.05M | -17.26M | -12.93M | -13.51M | -14.73M |
Adj. Free Cash Flow | -196.41M | -90.67M | -102.62M | 129.96M | -75.01M | -71.91M | -132.24M | -58.91M | -43.59M | -51.45M | -29.38M | -36.08M | -39.08M | -31.54M | -26.35M | -28.27M | -24.98M | -22.65M | -19.33M | -15.12M | -15.57M | -16.65M |
Maintenance CapEx | -1.83M | -967K | n/a | n/a | -663K | -1.33M | n/a | -457K | -973K | -1.33M | -838K | -603K | -884K | -43K | n/a | n/a | -1.94M | n/a | -605K | -451.04K | n/a | n/a |
Growth CapEx | n/a | n/a | -333K | -42K | n/a | n/a | -1.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.1M | n/a | -401K | n/a | -6.96K | -578K | -1M |
Owner Earnings | -165.21M | -76.14M | -90.5M | 142.21M | -63.14M | -61.67M | -121.66M | -49.69M | -33.86M | -45.14M | -24.59M | -30.78M | -34.34M | -27.89M | -23.37M | -24.17M | -21.93M | -19.65M | -17.26M | -12.92M | -12.93M | -13.72M |
Add to Watchlist
Select watchlists to add or remove IDYA